Floatz logo

Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tinengotinib
Prostate Cancer
Memorial Sloan Kettering Cancer CenterP1/2CC (46)
Tislelizumab
Endometrial Carcinoma
HutchmedP1/2CC (46)
tj-68
Amyotrophic Lateral Sclerosis
Hiroshi MitsumotoP1/2CC (46)
Tolinapant
Fallopian Tube Carcinosarcoma
National Cancer Institute (NCI)P1/2CC (46)
Tolinapant
Ovarian Carcinosarcoma
National Cancer Institute (NCI)P1/2CC (46)
Tumor-Draining Lymph Node-Derived Lymphocyte
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP1/2CC (46)
Utomilumab
Metastatic Prostate Carcinoma
M.D. Anderson Cancer CenterP1/2CC (46)
Utomilumab
Prostate Cancer
M.D. Anderson Cancer CenterP1/2CC (46)
Vorinostat
Lung Cancer
H. Lee Moffitt Cancer Center and Research InstituteP1/2CC (46)
Wrair-Pam-Cf1
Cystic Fibrosis
National Institute of Allergy and Infectious Diseases (NIAID)P1/2CC (46)
Zanidatamab
Gastroesophageal Junction Adenocarcinoma
Boehringer IngelheimP1/2CC (46)
Zanzalintinib
Non-Small Cell Lung Carcinoma
ExelixisP1/2CC (46)
zx-101a
Non-Hodgkin Lymphoma
Nanjing Zenshine PharmaceuticalsP1/2CC (46)
zx-101a
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Nanjing Zenshine PharmaceuticalsP1/2CC (46)
1.0% ip-001 for
Soft Tissue Sarcoma
Immunophotonics, Inc.P1/2CC (45)
161tb rad402
Castration-Resistant Prostate Carcinoma
Radiopharm Theranostics, LtdP1/2CC (45)
177lu-betabart
Non-Small Cell Lung Carcinoma
Radiopharm Theranostics, LtdP1/2CC (45)
[177lu]lu-dpi-4452
Urothelial Carcinoma
ITM Oncologics GmbHP1/2CC (45)
18f-op-801
Amyotrophic Lateral Sclerosis
Ashvattha Therapeutics, Inc.P1/2CC (45)
18f-op-801
Parkinson Disease
Ashvattha Therapeutics, Inc.P1/2CC (45)
[203Pb]Pb-MP0712
Small Cell Lung Carcinoma
Molecular Partners AGP1/2CC (45)
[203pb]pb-psv359
Mesothelioma
Perspective TherapeuticsP1/2CC (45)
[212pb]pb-mp0712
Small Cell Lung Carcinoma
Molecular Partners AGP1/2CC (45)
[212pb]pb-psv359
Mesothelioma
Perspective TherapeuticsP1/2CC (45)
225ac-sso110
Cutaneous Neuroendocrine Carcinoma
Ariceum Therapeutics GmbHP1/2CC (45)
Showing 2851 to 2875 of 6,305 assets
PreviousPage 115 of 253Next